1. Home
  2. LSBK vs CMPX Comparison

LSBK vs CMPX Comparison

Compare LSBK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

HOLD

Current Price

$18.98

Market Cap

143.2M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

154.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
CMPX
Founded
1891
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.2M
154.9M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
LSBK
CMPX
Price
$18.98
$0.76
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
★ $5.46
AVG Volume (30 Days)
16.9K
★ 3.0M
Earning Date
10-21-2026
11-17-2026
Dividend Yield
★ 1.92%
N/A
EPS Growth
★ 49.23
N/A
EPS
★ 0.56
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.02
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$13.83
$0.73
52 Week High
$19.34
$6.88

Technical Indicators

Market Signals
Indicator
LSBK
CMPX
Relative Strength Index (RSI) 57.83 26.13
Support Level $16.87 $0.73
Resistance Level $18.93 $2.02
Average True Range (ATR) 0.41 0.05
MACD 0.04 0.03
Stochastic Oscillator 67.46 12.83

Price Performance

Historical Comparison
LSBK
CMPX

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: